Fractyl Health shareholders can lead securities fraud lawsuit

BENSALEM, Pa., Sept. 3, 2026 /CourierPR/ -- Fractyl Health, Inc. shareholders who have suffered significant financial losses are being given the opportunity to take the lead in a securities fraud lawsuit against the company, according to a recent announcement by The Law Offices of Howard G. Smith.

The law firm has advised investors who experienced a financial downturn due to Fractyl Health, Inc. (GUTS) to contact them before October 20, 2026, to participate in the ongoing securities fraud class action lawsuit. The deadline is crucial for those who wish to be named as lead plaintiffs.

The lawsuit centers around alleged material misrepresentations and omissions made by Fractyl Health, Inc. between January 13, 2025, and January 29, 2026. Specifically, the complaint alleges that the company failed to disclose important facts regarding the efficacy of its product, Revita, and operational issues at certain clinical sites that potentially compromised the integrity of its clinical results.

The complaint suggests that due to these undisclosed issues, Fractyl Health's public statements regarding the prospects of Revita and the REMAIN-1 Midpoint Cohort's ability to assess Revita’s efficacy were overly optimistic and therefore misleading to investors.

To be part of the class action lawsuit, investors do not need to take any immediate action. They can choose to retain their own legal counsel or remain as an absent member of the class. The firm notes that this press release may be considered attorney advertising in some jurisdictions under applicable laws and ethical rules.

The Law Offices of Howard G. Smith is committed to representing the interests of affected shareholders and ensuring they have the opportunity to seek justice for their financial losses.